Education
About Us
Working with TipRanks
Follow Us
China Health Group Ltd (HK:0673)
:0673
RESEARCH TOOLSreports
0673 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.13 - HK$0.96
Previous CloseN/A
Volume864.00K
Average Volume (3M)3.15M
Market Cap
HK$147.49M
Enterprise ValueHK$472.16M
Total Cash (Recent Filing)HK$2.41M
Total Debt (Recent Filing)HK$5.54M
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Nov 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding491,644,780
10 Day Avg. Volume586,810
30 Day Avg. Volume3,153,547
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)5.53
Price to Sales (P/S)0.00
P/FCF Ratio-49.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China Health Group News
PremiumCompany Announcements
China Health Group Reports Increased Losses for FY 2025
PremiumCompany Announcements
China Health Group Restructures to Resolve Financial Disputes
PremiumCompany Announcements
China Health Group Suspends Trading Pending Annual Results
PremiumCompany Announcements
China Health Group Delays 2025 Annual Results, Trading Suspended
PremiumCompany Announcements
China Health Group’s Acquisition Deal Lapses Without Impact on Operations
PremiumCompany Announcements
China Health Group Issues Profit Warning for FY2025PremiumCompany Announcements
China Health Group Schedules Board Meeting for Fiscal Year Results
PremiumCompany Announcements
China Health Group Delays Circular Dispatch for Strategic Initiatives0673 FAQ
What was China Health Group Ltd’s price range in the past 12 months?
China Health Group Ltd lowest stock price was HK$0.13 and its highest was HK$0.96 in the past 12 months.
What is China Health Group Ltd’s market cap?
China Health Group Ltd’s market cap is HK$147.49M.
When is China Health Group Ltd’s upcoming earnings report date?
China Health Group Ltd’s upcoming earnings report date is Nov 26, 2025 which is in 143 days.
How were China Health Group Ltd’s earnings last quarter?
China Health Group Ltd released its earnings results on Jun 30, 2025. The company reported -HK$0.102 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.102.
Is China Health Group Ltd overvalued?
According to Wall Street analysts China Health Group Ltd’s price is currently Overvalued.
Does China Health Group Ltd pay dividends?
China Health Group Ltd does not currently pay dividends.
What is China Health Group Ltd’s EPS estimate?
China Health Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Health Group Ltd have?
China Health Group Ltd has 491,644,780 shares outstanding.
What happened to China Health Group Ltd’s price movement after its last earnings report?
China Health Group Ltd reported an EPS of -HK$0.102 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.143%.
Which hedge fund is a major shareholder of China Health Group Ltd?
Currently, no hedge funds are holding shares in HK:0673
China Health Group Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
-68.42%
12-Months-Change
Fundamentals
Return on Equity
-71.31%
Trailing 12-Months
Asset Growth
-49.05%
Trailing 12-Months
Company Description
China Health Group Ltd
China Health Group Limited (0673) is a healthcare service provider based in Hong Kong, operating primarily in the Greater China region. The company focuses on offering comprehensive healthcare services that include hospital management, healthcare consulting, and investment in medical facilities. China Health Group is dedicated to enhancing the quality and accessibility of healthcare services by leveraging innovative technologies and strategic partnerships within the healthcare sector.
Technical Analysis
Frontage Holdings Corp.
―
Sino Biopharmaceutical
―
The United Laboratories International Holdings
―
Livzon Pharmaceutical Group
―
CSPC Pharmaceutical Group
―